🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates the safety and efficacy of brimonidine 0.1% ophthalmic...
Status
Completed
Location
Multiple Locations
Start Date
2003-05
Trial ID
NCT00652483
Treatments Being Tested
This study evaluates the safety and efficacy of brimonidine 0.2%/timolol 0....
Status
Completed
Location
Multiple Locations
Start Date
2003-06
Trial ID
NCT00652106
The purpose of this study was to compare the short term effects of two intr...
Status
Completed
Location
Contact Alcon Call Center at 1-888-451-3937 For Trial Locations
Start Date
2009-02
Trial ID
NCT00800540
To evaluate the efficacy of Combo compared to its individual components and...
Status
Completed
Location
104 Butchertown Clinical Trials
Start Date
2022-11-18
Trial ID
NCT05591755
The purpose of this study was to evaluate the efficacy and safety of a fixe...
Status
Completed
Location
Multiple Locations
Start Date
2011-02
Trial ID
NCT01297517
Stage 1 is a patient-masked, dose-escalation, safety evaluation of brimonid...
Status
Completed
Location
Multiple Locations
Start Date
2008-05-01
Trial ID
NCT00658619
Treatments Being Tested
The goal of this observational study is to evaluate whether prostaglandin a...
Status
Not Yet Recruiting
Location
Department of Ophthalmology University of Bonn
Start Date
2026-05
Trial ID
NCT07074782
In this study, investigators will be examining the intraocular pressure low...
Status
Completed
Location
Multiple Locations
Start Date
2016-12-15
Trial ID
NCT03513172
Treatments Being Tested
This study will evaluate the efficacy and safety of brimonidine 0.1% three-...
Status
Completed
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT00457795
Treatments Being Tested
The purpose of this study is to evaluate the clinical efficacy of the BREME...
Status
Completed
Location
Allegisa
Start Date
2021-02-01
Trial ID
NCT03235232
Treatments Being Tested